Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 156

1.

Cerebrospinal fluid high-mobility group box protein 1 in neuromyelitis optica and multiple sclerosis.

Wang H, Wang K, Wang C, Xu F, Zhong X, Qiu W, Hu X.

Neuroimmunomodulation. 2013;20(2):113-8. doi: 10.1159/000345994. Epub 2013 Jan 10.

PMID:
23328212
2.

CSF high-mobility group box 1 is associated with intrathecal inflammation and astrocytic damage in neuromyelitis optica.

Uzawa A, Mori M, Masuda S, Muto M, Kuwabara S.

J Neurol Neurosurg Psychiatry. 2013 May;84(5):517-22. doi: 10.1136/jnnp-2012-304039. Epub 2012 Dec 19.

PMID:
23255728
3.

Notable increased cerebrospinal fluid levels of soluble interleukin-6 receptors in neuromyelitis optica.

Wang H, Wang K, Zhong X, Dai Y, Qiu W, Wu A, Hu X.

Neuroimmunomodulation. 2012;19(5):304-8. doi: 10.1159/000339302. Epub 2012 Jul 6.

PMID:
22777162
4.

Cerebrospinal fluid IL-21 levels in Neuromyelitis Optica and multiple sclerosis.

Wu A, Zhong X, Wang H, Xu W, Cheng C, Dai Y, Bao J, Qiu W, Lu Z, Hu X.

Can J Neurol Sci. 2012 Nov;39(6):813-20.

PMID:
23041403
5.

Markedly increased CSF interleukin-6 levels in neuromyelitis optica, but not in multiple sclerosis.

Uzawa A, Mori M, Ito M, Uchida T, Hayakawa S, Masuda S, Kuwabara S.

J Neurol. 2009 Dec;256(12):2082-4. doi: 10.1007/s00415-009-5274-4.

PMID:
19655191
6.

Characteristic cerebrospinal fluid cytokine/chemokine profiles in neuromyelitis optica, relapsing remitting or primary progressive multiple sclerosis.

Matsushita T, Tateishi T, Isobe N, Yonekawa T, Yamasaki R, Matsuse D, Murai H, Kira J.

PLoS One. 2013 Apr 18;8(4):e61835. doi: 10.1371/journal.pone.0061835. Print 2013.

7.

Elevated plasma high-mobility group box 1 protein is a potential marker for neuromyelitis optica.

Wang KC, Tsai CP, Lee CL, Chen SY, Chin LT, Chen SJ.

Neuroscience. 2012 Dec 13;226:510-6. doi: 10.1016/j.neuroscience.2012.08.041.

PMID:
23122444
8.

Cerebrospinal fluid BAFF and APRIL levels in neuromyelitis optica and multiple sclerosis patients during relapse.

Wang H, Wang K, Zhong X, Qiu W, Dai Y, Wu A, Hu X.

J Clin Immunol. 2012 Oct;32(5):1007-11. doi: 10.1007/s10875-012-9709-9. Epub 2012 May 30.

PMID:
22644841
9.

Impaired regulatory function and enhanced intrathecal activation of B cells in neuromyelitis optica: distinct from multiple sclerosis.

Quan C, Yu H, Qiao J, Xiao B, Zhao G, Wu Z, Li Z, Lu C.

Mult Scler. 2013 Mar;19(3):289-98. doi: 10.1177/1352458512454771. Epub 2012 Aug 3.

PMID:
22864301
10.

Increased soluble C5b-9 in CSF of neuromyelitis optica.

Wang H, Wang K, Wang C, Qiu W, Lu Z, Hu X.

Scand J Immunol. 2014 Feb;79(2):127-30. doi: 10.1111/sji.12132.

11.

Interleukin-17-secreting T cells in neuromyelitis optica and multiple sclerosis during relapse.

Wang HH, Dai YQ, Qiu W, Lu ZQ, Peng FH, Wang YG, Bao J, Li Y, Hu XQ.

J Clin Neurosci. 2011 Oct;18(10):1313-7. doi: 10.1016/j.jocn.2011.01.031. Epub 2011 Jul 26.

PMID:
21795048
12.

Cerebrospinal fluid levels of CXCL13 are elevated in neuromyelitis optica.

Zhong X, Wang H, Dai Y, Wu A, Bao J, Xu W, Cheng C, Lu Z, Qiu W, Hu X.

J Neuroimmunol. 2011 Dec 15;240-241:104-8. doi: 10.1016/j.jneuroim.2011.10.001. Epub 2011 Oct 28.

PMID:
22036953
13.

Cerebrospinal fluid α-synuclein levels are elevated in multiple sclerosis and neuromyelitis optica patients during replase.

Wang H, Wang K, Xu W, Wang C, Qiu W, Zhong X, Dai Y, Wu A, Hu X.

J Neurochem. 2012 Jul;122(1):19-23. doi: 10.1111/j.1471-4159.2012.07749.x. Epub 2012 Apr 19.

14.

Urinary trypsin inhibitor levels are reduced in cerebrospinal fluid of multiple sclerosis and neuromyelitis optica patients during relapse.

Shu Y, Li R, Yang Y, Dai Y, Qiu W, Chen Y, Zhao Z, Lu Z, Hu X.

Neurochem Int. 2015 Feb;81:28-31. doi: 10.1016/j.neuint.2014.12.008. Epub 2014 Dec 30.

PMID:
25555815
15.

Analyses of haptoglobin level in the cerebrospinal fluid and serum of patients with neuromyelitis optica and multiple sclerosis.

Chang KH, Tseng MY, Ro LS, Lyu RK, Tai YH, Chang HS, Wu YR, Huang CC, Hsu WC, Kuo HC, Chu CC, Chen CM.

Clin Chim Acta. 2013 Feb 18;417:26-30. doi: 10.1016/j.cca.2012.12.008. Epub 2012 Dec 21.

PMID:
23262373
16.

Cerebrospinal fluid light and heavy neurofilaments in neuromyelitis optica.

Wang H, Wang C, Qiu W, Lu Z, Hu X, Wang K.

Neurochem Int. 2013 Dec;63(8):805-8. doi: 10.1016/j.neuint.2013.10.008. Epub 2013 Oct 23.

PMID:
24161620
17.

Cerebrospinal fluid levels of iodothyronines and nerve growth factor in patients with multiple sclerosis and neuromyelitis optica.

Jiang Y, Yang Y, Zhang B, Peng F, Bao J, Hu X.

Neuro Endocrinol Lett. 2009 Mar;30(1):85-90.

PMID:
19300400
18.

Increased levels of CSF CD59 in neuromyelitis optica and multiple sclerosis.

Uzawa A, Mori M, Uchida T, Masuda H, Ohtani R, Kuwabara S.

Clin Chim Acta. 2016 Jan 30;453:131-3. doi: 10.1016/j.cca.2015.12.013. Epub 2015 Dec 11.

PMID:
26686775
19.

Distinguishing the cerebrospinal fluid cytokine profile in neuropsychiatric systemic lupus erythematosus from other autoimmune neurological diseases.

Ichinose K, Arima K, Ushigusa T, Nishino A, Nakashima Y, Suzuki T, Horai Y, Nakajima H, Kawashiri SY, Iwamoto N, Tamai M, Nakamura H, Origuchi T, Motomura M, Kawakami A.

Clin Immunol. 2015 Apr;157(2):114-20. doi: 10.1016/j.clim.2015.01.010. Epub 2015 Feb 3.

PMID:
25656641
20.

Increased plasma interleukin-32 expression in patients with neuromyelitis optica.

Wang H, Wang K, Wang C, Xu F, Qiu W, Hu X.

J Clin Immunol. 2013 Apr;33(3):666-70. doi: 10.1007/s10875-012-9837-2. Epub 2012 Nov 21.

PMID:
23180362

Supplemental Content

Support Center